UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index

Clinical cancer research, 2019-09, Vol.25 (18), p.5441-5448

2019

Link zum Volltext

Verfügbarkeit prüfen

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Leukemia, 2018-08, Vol.32 (8), p.1768-1777

2018

Link zum Volltext

Verfügbarkeit prüfen

Management of adverse events associated with idelalisib treatment: expert panel opinion

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2779-2786

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute renal failure associated with gefitinib therapy

Lung, 2006-08, Vol.184 (4), p.249-250

2006

Link zum Volltext

Verfügbarkeit prüfen

Ectopic hepatocellular carcinoma of the diaphragm

Digestive diseases and sciences, 2007-04, Vol.52 (4), p.1118-1120

2007

Link zum Volltext

Verfügbarkeit prüfen

Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients

Clinica chimica acta, 2011-01, Vol.412 (1), p.181-185

2011

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow necrosis caused by metastatic colon cancer

Journal of clinical oncology, 2009-08, Vol.27 (23), p.e48-e48

2009

Link zum Volltext

Verfügbarkeit prüfen

Anaplastic large-cell lymphoma primarily infiltrating femoral muscles

Annals of hematology, 2005-11, Vol.84 (11), p.764-766

2005

Link zum Volltext

Verfügbarkeit prüfen

Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis

Journal of B.U. ON., 2013-10, Vol.18 (4), p.1058-1061

2013

Link zum Volltext

Verfügbarkeit prüfen

Successful metronomic low-dose cyclophosphamide therapy in an older patient with advanced mucosa-associated lymphoid tissue lymphoma

Annals of hematology, 2009-12, Vol.88 (12), p.1257-1259

2009

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor

Southern medical journal (Birmingham, Ala.), 2009-05, Vol.102 (5), p.546

2009

Link zum Volltext

Verfügbarkeit prüfen

Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer

Onkologie, 2010-01, Vol.33 (1-2), p.45-11

2010

Link zum Volltext

Verfügbarkeit prüfen

Production of Beta‐HCG by Spermatic Cord Leiomyosarcoma: A Paraneoplastic Syndrome?

Journal of andrology, 2006-09, Vol.27 (5), p.643-644

2006

Link zum Volltext

Verfügbarkeit prüfen

Ectopic ACTH Syndrome Associated With Large-Cell Neuroendocrine Carcinoma of the Lung

The American journal of the medical sciences, 2007-12, Vol.334 (6), p.487-489

2007

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma

Hematology/oncology and stem cell therapy, 2009, Vol.2 (2), p.371-372

2009

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer metastatic to the masticator space

Onkologie, 2009-06, Vol.32 (6), p.349-351

2009

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer mimicking acute myocardial infarction on electrocardiogram

The American journal of emergency medicine, 1999, Vol.17 (1), p.86-88

1999

Link zum Volltext

Verfügbarkeit prüfen

Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation

Transplantation, 2002-07, Vol.74 (2), p.182

2002

Link zum Volltext

Verfügbarkeit prüfen

Isolated temporal bone metastasis in a patient with non-small cell lung cancer

European journal of radiology extra, 2005-09, Vol.55 (3), p.75-77

2005

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed or refractory hairy cell leukaemia

British journal of clinical pharmacology, 2020-07, Vol.86 (7), p.1367-1376

2020

Link zum Volltext

Verfügbarkeit prüfen

Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study

Blood, 2017-12, Vol.130, p.2765-2765

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of moxetumomab pasudotox (moxe) in adult patients (pts) with relapsed/refractory hairy cell leukemia (HCL) in relation to drug exposure, baseline disease burden, and immunogenicity

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7060-7060

2018

Link zum Volltext

Verfügbarkeit prüfen

Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia

Pediatric blood & cancer, 2020-05, Vol.67 (5), p.e28112-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Remissions with Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox Are Associated with Improved Complete Remission Durations during Phase I and III Testing

Blood, 2018-11, Vol.132 (Supplement 1), p.1861-1861

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of moxetumomab pasudotox (Moxe), an immunotoxin targeting CD22, in adult patients (Pts) with relapsed or refractory hairy cell leukemia (HCL)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7061-7061

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)
Berichte
(2)

Sprache

Englisch
(35)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(22)
Male
(17)
Female
(11)
Adult
(10)
Middle Aged
(10)
Oncology
(10)
Aged
(9)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Aged, 80 And Over
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Hematology
(5)
Deoxycytidine - Administration & Dosage
(4)
Deoxycytidine - Analogs & Derivatives
(4)
Lung Cancer
(4)
Treatment Outcome
(4)
Antineoplastic Agents - Therapeutic Use
(3)
Bone Neoplasms - Secondary
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Management of adverse events associated with idelalisib treatment: expert panel opinion

Acute renal failure associated with gefitinib therapy

Ectopic hepatocellular carcinoma of the diaphragm

Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients

Bone marrow necrosis caused by metastatic colon cancer

Anaplastic large-cell lymphoma primarily infiltrating femoral muscles

Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis

Successful metronomic low-dose cyclophosphamide therapy in an older patient with advanced mucosa-associated lymphoid tissue lymphoma

Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor

Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer

Production of Beta‐HCG by Spermatic Cord Leiomyosarcoma: A Paraneoplastic Syndrome?

Ectopic ACTH Syndrome Associated With Large-Cell Neuroendocrine Carcinoma of the Lung

Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma

Lung cancer metastatic to the masticator space

Lung cancer mimicking acute myocardial infarction on electrocardiogram

Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation

Isolated temporal bone metastasis in a patient with non-small cell lung cancer

Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed or refractory hairy cell leukaemia

Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study

Efficacy and safety of moxetumomab pasudotox (moxe) in adult patients (pts) with relapsed/refractory hairy cell leukemia (HCL) in relation to drug exposure, baseline disease burden, and immunogenicity

Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia

Molecular Remissions with Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox Are Associated with Improved Complete Remission Durations during Phase I and III Testing

Pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of moxetumomab pasudotox (Moxe), an immunotoxin targeting CD22, in adult patients (Pts) with relapsed or refractory hairy cell leukemia (HCL)

Suchergebnisse filtern